Also, the use of the number p-tau-AT8 aggregates as a single biomarker in serum gave us a low diagnostic accuracy of 55% (AUC = 55%) in early AD and 74% in AD with moderate dementia (Supplementary Fig. 3A, C). Here, MAPT is linked to Alzheimer disease.